Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of California, Irvine
M.D. Anderson Cancer Center
ViroMissile, Inc.
Washington University School of Medicine
Essen Biotech
Alliance for Clinical Trials in Oncology
University of Nebraska
National Cancer Institute (NCI)
Adela, Inc
M.D. Anderson Cancer Center
Eli Lilly and Company
Var2 Pharmaceuticals